NEXI NexImmune Corporation Company Short-Term Debt

NexImmune - graphic logo of issuer NEXI

NexImmune, Inc. (NEXI) leverages the expertise of leading immunologists developing cutting-edge tumor-fighting methods in high-tech laboratories. The business is currently undergoing a transformation period, updating its research vector to overcome stagnation in drug development. This price chart reflects the current 0.00, which, combined with a broad spectrum of clinical trials, helps the company minimize systemic risks.

NEXI neximmune.com Short-Term Debt (07/04/2022 - 08/04/2024)

Analytical breakdowns and data insights for company NexImmune Corporation (NEXI)

- current quotes and average value forecast:
Price Chart NexImmune|NEXI - Average Forecast Price
- market capitalization data:
Market Value NexImmune, Inc.|NEXI - Total Company Value
- shareholders' equity book value data:
Net Assets per Single Share NexImmune|NEXI - Total Stockholders' Equity|Market Capitalization to Book Value Ratio neximmune.com|NEXI - Company Balance Sheet Assets
- company total debt and liquidity indicators:
Total Debt to Equity Ratio NexImmune, Inc.|NEXI - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio NexImmune, Inc.|NEXI - Aggregate Debt Obligations|Debts to Book Capitalization NexImmune, Inc.|NEXI - Long-Term Debt Volume|Company Short-Term Debt NexImmune|Quick Liquidity neximmune.com
- earnings and multiples data:
NEXI - Net Income
General company analysis:NexImmune (NEXI)
Flagship merchandise of neximmune.com

This indicator measures total liabilities with a maturity of up to one year, determining management's ability to balance operational liquidity against investment risk. By analyzing the history of short-term loans and borrowings, an investor assesses whether excessive debt conservatism is hindering the development of the T-cell programming biopharmaceutical platform of NexImmune, Inc. (NEXI), whose long-term value is based on the protection of intellectual property.

Competitors of NexImmune, Inc.

IBRX - Company Short-Term Debt|Short-Term Debt Immunocore Holdings|Janux Pharma (JANX) - Company Short-Term Debt|RCUS (Arcus Corp) - Company Short-Term Debt|Company Short-Term Debt Zymeworks Inc.|Short-Term Debt tangotx.com TNGX|Company Short-Term Debts IOVA|Immatics NV (IMTX) - Short-Term Indebtedness|Xencor Corp - Company Current Liabilities|Compass Therapeutics Corp (CMPX) - Short-Term Debt|REPL: Company Current Liabilities|Company Short-Term Loans and Borrowings LYEL (lyell.com)|IPHA: Company Short-Term Debts|PYXS - Short-Term Debt Volume|Company Short-Term Debt Compugen Ltd|Company Current Liabilities IO Biotech Inc. (IOBT)|Company Short-Term Debt Sutro Biopharma, Inc. (STRO)|Company Current Liabilities minktherapeutics.com INKT|Werewolf Therapeutics, Inc. - Company Current Liabilities|Company Short-Term Debts Immix Biopharma Inc. IMMX|ALXO - Company Short-Term Debt|CUE (Cue Biopharma Inc.) - Company Short-Term Indebtedness|pdsbiotech.com (PDSB) - Company Short-Term Debt|Short-Term Debt Sonnet BioTherapeutics Holdings (SONN)|Company Current Liabilities MAIA|LIMN - Short-Term Indebtedness|Company Current Liabilities LVTX (LAVA Therapeutics N.V.)|Amount of Current Liabilities NXTC|Company Short-Term Debts LPTX (Leap Therapeutics)|Company Short-Term Loans and Borrowings INTS|Sensei Bio - Company Short-Term Debts|Short-Term Debt Theriva Biologics Inc|gritstonebio.com (GRTS) - Company Short-Term Debt|Kineta Corp - Company Short-Term Loans and Borrowings|TSBX (Turnstone Biologics Corp) - Company Short-Term Debts|Company Short-Term Debts vaccinex.com|Company Short-Term Debt Harpoon Therapeutics, Inc. (HARP)